International Edition
Latest News
Health

Minoxidil Demand Surges 73% in Lugo, Straining Hypertension Drug Supplies

Minoxidil demand surged 73 percent in Lugo province over roughly two years, straining supplies of the blood-pressure drug Loniten, the pharmaceutical distributor Bidafarma reported on November 22, according to Elprogreso. The increase reflects earlier consultations for androgenetic alopecia,…

Minoxidil demand surged 73 percent in Lugo province over roughly two years, straining supplies of the blood-pressure drug Loniten, the pharmaceutical distributor Bidafarma reported on November 22, according to Elprogreso.

The increase reflects earlier consultations for androgenetic alopecia, which has lowered the average patient age and expanded use among women, pharmacists in the province told El Progreso. Santiago Torres Labandeira, a pharmacist in Lugo, said demand for oral minoxidil has increased. “We are making more and more, for both women and men,” staff at the Pérez y Nartallo pharmacy told the outlet. The Forján pharmacy confirmed the rise includes combinations with finasteride. Some pharmacies perceive the increase as even more acute and say demand for minoxidil products has tripled, pharmacists in the province told El Progreso.

Torres Labandeira explained that he detects that increment and perhaps more bluntly in the oral treatment.

Certain pharmacies continue to compound medications or preparations that alleviate problems that either find no solution in industry products or do so in an unsuitable format; in the case of minoxidil lotions, pharmaceutical laboratories sold the medication at a certain percentage but not at another, and pharmacists covered that gap in the market and also prepared minoxidil in oral form because, in some cases, dermatologists estimated it should be complemented or that was the best route of treatment, Torres Labandeira said.

Minoxidil was approved by the U.S. agency for oral use in 1979 as a vasodilator for severe hypertension. Physicians noticed unexpected hair growth in patients, prompting development of a topical version approved for men in 1988 and for women in 1991.

Loniten, the oral minoxidil drug marketed by Upjohn, which is now part of Pfizer, has been under controlled distribution since April because prescriptions for hair loss have led to difficulties finding it in pharmacies. The drug has the highest doses of minoxidil, 10 grams. Minogal, another oral formulation used for hypertension, also faces intermittent shortages. Both drugs are prescribed off-label for alopecia; compounding pharmacies prepare capsules from physician prescriptions.

The same doses can be obtained as a magistral formulation in capsules that pharmacies prepare following the prescription issued by the physician.

The laboratory is carrying out what is called a controlled distribution, since it has limited units, and it can be requested as a foreign medication only if the patient takes it to control blood pressure, the report said. Minogal is marketed industrially in two other doses; it can be found although punctual distribution cuts also occur, the report said.

Lugo province, in northwestern Spain’s Galicia region, borders the Cantabrian Sea and the provinces of Ourense, Pontevedra, A Coruña, León, and Asturias. Its capital, Lugo city, originated as a Celtic settlement honouring the god Lugh, later becoming the Roman centre Lucus Augusti. The province comprises 67 municipalities and had a population of 325,048, with over a quarter living in the capital.

Lorenzo Armenteros, spokesperson for the Spanish Society of General and Family Physicians, said minoxidil is dispensed only by prescription and indicated solely for androgenetic alopecia, which follows distinct patterns in men and women.

About the author: Health Desk

Health Desk at Archynewsy.